Anika Therapeutics, Inc.
ANIK
$14.88
-$0.14-0.93%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.06M | -10.88M | -33.04M | -30.71M | -26.83M |
| Total Depreciation and Amortization | 5.40M | 5.58M | 5.70M | 4.29M | 5.08M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.88M | 17.31M | 37.53M | 34.14M | 32.80M |
| Change in Net Operating Assets | -9.74M | -823.00K | -2.06M | -6.47M | -10.67M |
| Cash from Operations | 6.47M | 11.19M | 8.13M | 6.28M | 5.40M |
| Capital Expenditure | -5.43M | -6.83M | -7.49M | -5.60M | -7.53M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 4.50M | 8.99M | 8.99M | 8.99M | 4.50M |
| Other Investing Activities | -2.38M | -2.57M | -3.41M | -3.57M | 0.00 |
| Cash from Investing | -3.31M | -401.00K | -1.91M | -1.99M | -4.85M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 500.00K | 500.00K | 558.00K | 558.00K | 761.00K |
| Repurchase of Common Stock | -15.96M | -11.05M | -11.18M | -11.17M | -12.66M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -15.46M | -10.55M | -10.63M | -14.60M | -15.89M |
| Foreign Exchange rate Adjustments | -51.00K | 86.00K | 21.00K | 323.00K | -246.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.35M | 322.00K | -4.38M | -9.66M | -15.26M |